Phio Pharmaceuticals Corp...

NASDAQ: PHIO · Real-Time Price · USD
2.21
0.02 (0.91%)
At close: Aug 15, 2025, 3:59 PM
2.12
-4.07%
After-hours: Aug 15, 2025, 05:02 PM EDT

Phio Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
35K 6.33M 193K 192K
Gross Profit
n/a -6.33M -193K -192K
Operating Income
-7.39M -10.82M -11.46M -13.51M
Interest Income
n/a n/a n/a n/a
Pretax Income
-7.15M -10.83M -11.48M -13.29M
Net Income
-7.15M -10.83M -11.3M -13.21M
Selling & General & Admin
3.74M 4.29M 4.45M 4.63M
Research & Development
3.64M 6.33M 7.01M 8.89M
Other Expenses
n/a -6.13M -18K 224K
Operating Expenses
7.39M 4.49M 11.46M 13.51M
Interest Expense
231K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 10.82M 11.46M 13.51M
Income Tax Expense
n/a n/a -175K -75K
Shares Outstanding (Basic)
7.87M 231K 126.16K 118.68K
Shares Outstanding (Diluted)
7.87M 231.51K 126.16K 118.68K
EPS (Basic)
-0.91 -46.87 -89.61 -111.32
EPS (Diluted)
-0.91 -46.76 -89.61 -111.32
EBITDA
-7.12M -10.64M -11.29M -13.09M
EBIT
-6.92M -10.83M -11.48M -13.51M
Depreciation & Amortization
35K 184K 193K 192K